Understand the source comparison
Best Peptides for Tennis Elbow: Mechanism Comparison
BPC-157 VEGF upregulation, angiogenesis promotion, fibroblast activation 250–500mcg daily subcutaneous VEGFR-2, nitric oxide synthase, collagen synthesis 8–12 weeks for measurable strength improvement First-line choice for chronic tendinosis with vascular insu
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, angiogenesis promotion, fibroblast activation
- 250–500mcg daily subcutaneous
- VEGFR-2, nitric oxide synthase, collagen synthesis
- 8–12 weeks for measurable strength improvement
- First-line choice for chronic tendinosis with vascular insufficiency. Strongest evidence base for tendon healing
- TB-500
- Actin sequestration, cell migration, MMP modulation
- 2–5mg twice weekly (month 1), then weekly
- G-actin binding, inflammatory cytokine suppression
- 4–8 weeks for reduced adhesions, 12+ weeks for full remodeling
- Best adjunct to BPC-157 when scar tissue or range-of-motion restriction is present. Anti-fibrotic effects clinically relevant
- Thymosin Beta-4
- Endothelial cell migration, anti-apoptotic signaling
- 5–10mg weekly
- Akt pathway, VEGF-A expression
- 10–16 weeks
- Parent compound of TB-500 with broader systemic effects. Less studied specifically for tendon repair but mechanistically sound
- GHK-Cu
- Collagen stimulation, antioxidant activity, tissue remodeling
- 1–3mg daily
- TGF-beta modulation, copper-dependent lysyl oxidase
- 12+ weeks
- Supports extracellular matrix reorganization but weaker evidence for tendon-specific pathology compared to BPC-157